We are live on ! Find out more
WIA

Wealthstreet Investment Advisors Portfolio holdings

AUM $3.71M
1-Year Est. Return 13.1%
This Fund
S&P 500
This Quarter Est. Return
+12.13%
1 Year Est. Return
+13.1%
3 Year Est. Return
+75.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$857M
AUM Growth
+$74.4M
Cap. Flow
+$16.5M
Cap. Flow %
1.93%
Top 10 Hldgs %
25.43%
Holding
353
New
18
Increased
76
Reduced
99
Closed
3

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$8.44M
2
SPYG icon
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
+$2.07M
3
IWR icon
iShares Russell Mid-Cap ETF
IWR
+$1.91M
4
IBM icon
IBM
IBM
+$1.78M
5
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$1.49M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$14.8M
2
UNH icon
UnitedHealth
UNH
+$661K
3
CVX icon
Chevron
CVX
+$653K
4
NTNX icon
Nutanix
NTNX
+$554K
5
LLY icon
Eli Lilly
LLY
+$545K

Sector Composition

Rank Sector Weight
1 Healthcare 18.24%
2 Technology 15.78%
3 Financials 11.55%
4 Industrials 10.57%
5 Consumer Staples 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBM icon
26
IBM
IBM
$217B
$8.44M 0.98%
65,828
+13,701
+26% +$1.78M
CAT icon
27
Caterpillar
CAT
$378B
$7.78M 0.91%
52,707
-100
-0.2% -$14K
MRK icon
28
Merck
MRK
$378B
$7.74M 0.9%
89,205
+105
+0.1% +$8.62K
WMT icon
29
Walmart Inc
WMT
$830B
$7.53M 0.88%
190,032
– –
C icon
30
Citigroup
C
$224B
$7.52M 0.88%
94,111
-419
-0.4% -$31K
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$139B
$7.51M 0.88%
34,320
– –
T icon
32
AT&T
T
$177B
$7.25M 0.85%
245,460
-1,825
-0.7% -$52.7K
CL icon
33
Colgate-Palmolive
CL
$73.4B
$7.12M 0.83%
103,451
-4,400
-4% -$300K
QCOM icon
34
Qualcomm
QCOM
$175B
$7.08M 0.83%
80,260
-498
-0.6% -$41.7K
RTX icon
35
RTX Corp
RTX
$286B
$6.93M 0.81%
73,523
-555
-0.7% -$50.3K
CSCO icon
36
Cisco
CSCO
$443B
$6.71M 0.78%
139,971
+11,548
+9% +$537K
KSU
37
DELISTED
Kansas City Southern
KSU
$6.36M 0.74%
41,511
– –
ACAD icon
38
Acadia Pharmaceuticals
ACAD
$5.1B
$6.31M 0.74%
147,470
-170
-0.1% -$7.4K
CI icon
39
Cigna
CI
$74.2B
$5.75M 0.67%
28,114
-185
-0.7% -$33.9K
IBB icon
40
iShares Biotechnology ETF
IBB
$10.8B
$5.74M 0.67%
47,626
+5,613
+13% +$626K
PM icon
41
Philip Morris
PM
$303B
$5.62M 0.66%
66,074
– –
EPD icon
42
Enterprise Products Partners
EPD
$84.5B
$5.15M 0.6%
183,026
-50
-0% -$1.35K
IYG icon
43
iShares US Financial Services ETF
IYG
$2.23B
$5.13M 0.6%
101,391
+11,925
+13% +$573K
MA icon
44
Mastercard
MA
$524B
$5M 0.58%
16,760
– –
MMP
45
DELISTED
Magellan Midstream Partners, L.P.
MMP
$4.92M 0.57%
78,206
– –
NSC icon
46
Norfolk Southern
NSC
$79.2B
$4.85M 0.57%
24,979
-15
-0.1% -$2.81K
PFE icon
47
Pfizer
PFE
$161B
$4.85M 0.57%
130,383
– –
HD icon
48
Home Depot
HD
$334B
$4.76M 0.56%
21,796
– –
MAR icon
49
Marriott International
MAR
$93.5B
$4.63M 0.54%
30,610
-260
-0.8% -$34.8K
GOOGL icon
50
Alphabet (Google) Class A
GOOGL
$4.18T
$4.59M 0.54%
68,560
-400
-0.6% -$25.8K
1
2
3 4 5

Similar funds

YEPV
Yorktown Energy Partners V New York $5.41M AUM
LSM
Light Sky Macro New York $1.34M AUM
FFIM
Founders Fund IV Management San Francisco, California $1.21M AUM
DTA
Disruptive Technology Advisers Austin, Texas $724K AUM 65.23% 1-Year Est. Return
BRC
Bedford Ridge Capital New York $464K AUM
GCM
Greyhound Capital Management London, United Kingdom $120K AUM
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return

Wealthstreet Investment Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Wealthstreet Investment Advisors held 353 positions worth $857M, up 9.5% from $783M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Wealthstreet Investment Advisors's Q4 2019 filing shows 18 new, 76 increased, 99 reduced and 3 closed positions. Its largest new stake was WisdomTree US SmallCap Dividend Fund: 20,012 shares worth $574K. The largest sale was Celgene Corp, an estimated $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Wealthstreet Investment Advisors's largest Q4 2019 buy was WisdomTree US SmallCap Dividend Fund: 20,012 shares worth $574K.
  • Wealthstreet Investment Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $8.44M increase.
  • Wealthstreet Investment Advisors's biggest Q4 2019 reduction was UnitedHealth, cutting an estimated $661K.
  • Wealthstreet Investment Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $14.8M.
  • Wealthstreet Investment Advisors's ten largest holdings make up 25% of its $857M portfolio in Q4 2019.
  • Wealthstreet Investment Advisors opened 18 new positions and closed 3 in Q4 2019.
  • Wealthstreet Investment Advisors's portfolio value rose 9.5% quarter-over-quarter to $857M.

Based on Wealthstreet Investment Advisors's 13F filing for Q4 2019, filed 22 Jan 2020.